Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-29 | Aimee S. Weisner Age 53 Qualifications. The Board of Directors concluded that Ms. Weisner’s extensive in-house legal and compliance experience with different medical device companies, including an in-depth understanding of regulatory issues, corporate governance, risk management, intellectual property, corporate transactions, human resources, and internal audit, her significant experience in the ophthalmic industry, and her prior service on the boards of several U.S. public companies in the medical device and pharmaceutical fields, qualify her to serve on our Board of Directors. |
| 2023-04-26 | Aimee S. Weisner Director since June 2022 Age 54 ... The current members of the Nominating and Governance Committee are Aimee Weisner, who has served as Chair since June 2022, Stephen Farrell, Dr. Elizabeth Yeu, and Dr. K. Peony Yu. ... The current members of the Compensation Committee are Aimee Weisner, who has served as chair since June 2022, Dr. Gilbert H. Kliman, and Dr. Elizabeth Yeu. ... 2022 Director Compensation ... Aimee S. Weisner Fees Earned or Paid in Cash $40,797 Option Awards $180,009 Total $220,806. |
| 2024-04-24 | Ms. Weisner earned a B.A. from California State University, Fullerton, and a J.D. from Loyola Law School, Los Angeles. |
Data sourced from SEC filings. Last updated: 2025-08-30